Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jun;188(6):1858-1862.
doi: 10.1002/ajmg.a.62699. Epub 2022 Feb 21.

LMOD2-related dilated cardiomyopathy presenting in late infancy

Affiliations
Case Reports

LMOD2-related dilated cardiomyopathy presenting in late infancy

Erica Lay et al. Am J Med Genet A. 2022 Jun.

Abstract

Leiomodin-2 (LMOD2) is an important regulator of the thin filament length, known to promote elongation of actin through polymerization at pointed ends. Mice with Lmod2 deficiency die around 3 weeks of age due to severe dilated cardiomyopathy (DCM), resulting from decreased heart contractility due to shorter thin filaments. To date, there have been three infants from two families reported with biallelic variants in LMOD2, presenting with perinatal onset DCM. Here, we describe a third family with a child harboring a previously described homozygous frameshift variant, c.1243_1244delCT (p.L415Vfs*108) with DCM, presenting later in infancy at 9 months of age. Family history was relevant for a sibling who died suddenly at 1 year of age after being diagnosed with cardiomegaly. LMOD2-related cardiomyopathy is a rare form of inherited cardiomyopathy resulting from thin filament length dysregulation and should be considered in genetic evaluation of newborns and infants with suspected autosomal recessive inheritance or sporadic early onset cardiomyopathy.

Keywords: LMOD2; autosomal recessive disease; dilated cardiomyopathy; loss of function variant; short thin filament length.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
A) Pedigree suggestive of autosomal recessive inheritance pattern of LMOD2-related cardiac disease in the family. The sibling of the patient (IV-3) died at 12 months of age in an emergency room, hours after being diagnosed with cardiomegaly. Consanguinity status is unknown. B) Sanger sequencing confirming a homozygous deletion of CT at c.1243_1244 in the proband, compared to the reference sequence (above) and to the sequences of the proband’s mother and father (below), which show a heterozygous deletion of CT at c.1243_1244.
Figure 2:
Figure 2:
A) Gross photo of opened left ventricle in explanted heart. B) The ventricular interstitium is mildly expanded with thin fibrous bands (Masson trichrome stain, scale bar = 100 microns). C) The normal left ventricular endocardium is above. Enlarged, darkly stained, hyperchromatic nuclei with perinuclear clearing reflect moderate myocyte hypertrophy (hematoxylin & eosin stain, scale bar = 50 microns). D) Electron microscopy of a left ventricular myocyte with grossly normal mitochondria (*) and degenerative Z-band streaming across a sarcomere (arrow). An intercalated disc (arrowheads) is along the left margin (scale bar = 1 micron).

References

    1. Ahrens-Nicklas RC, Pappas CT, Farman GP, Mayfield RM, Larrinaga TM, Medne L, Ritter A, Krantz ID, Murali C, Lin KY, Berger JH, Yum SW, Carreon CK, & Gregorio CC (2019). Disruption of cardiac thin filament assembly arising from a mutation in LMOD2: A novel mechanism of neonatal dilated cardiomyopathy. Sci Adv, 5(9), eaax2066. 10.1126/sciadv.aax2066 - DOI - PMC - PubMed
    1. Chereau D, Boczkowska M, Skwarek-Maruszewska A, Fujiwara I, Hayes DB, Rebowski G, Lappalainen P, Pollard TD, & Dominguez R (2008). Leiomodin is an actin filament nucleator in muscle cells. Science, 320(5873), 239–243. 10.1126/science.1155313 - DOI - PMC - PubMed
    1. Greenway SC, Fruitman D, Ferrier R, Huculak C, Marcadier J, Sergi C, & Bernier FP (2021). Early Death of 2 Siblings Related to Mutations in <em>LMOD2</em>, a Recently Discovered Cause of Neonatal Dilated Cardiomyopathy. CJC Open, 3(10), 1300–1302. 10.1016/j.cjco.2021.07.017 - DOI - PMC - PubMed
    1. Herkert JC, Abbott KM, Birnie E, Meems-Veldhuis MT, Boven LG, Benjamins M, du Marchie Sarvaas GJ, Barge-Schaapveld D, van Tintelen JP, van der Zwaag PA, Vos YJ, Sinke RJ, van den Berg MP, van Langen IM, & Jongbloed JDH (2018). Toward an effective exome-based genetic testing strategy in pediatric dilated cardiomyopathy. Genet Med, 20(11), 1374–1386. 10.1038/gim.2018.9 - DOI - PubMed
    1. Lipshultz SE, Cochran TR, Briston DA, Brown SR, Sambatakos PJ, Miller TL, Carrillo AA, Corcia L, Sanchez JE, Diamond MB, Freundlich M, Harake D, Gayle T, Harmon WG, Rusconi PG, Sandhu SK, & Wilkinson JD (2013). Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies. Future Cardiol, 9(6), 817–848. 10.2217/fca.13.66 - DOI - PMC - PubMed

Publication types